期刊文献+

维格列汀的合成工艺改进 被引量:2

Process Improvement on Synthesis of Vildagliptin
下载PDF
导出
摘要 以L-脯氨酰胺为起始原料,经氯乙酰氯酰化及三聚氰氯脱水一锅法制得(S)-N-氯乙酰基-2-氰基吡咯烷(4);4与3-氨基-1-金刚烷醇经亲核取代反应合成了维格列汀,总收率75%,其结构经1H NMR和MS(ESI)确证。 (S) -N-chloracetyl-2-cyanopyrrolidines (4) was prepared by the reaction of acetylation reac- tion and dehydration reaction using L-prolinamide as starting material. Vildagliptin with total yield of 75% was synthesized by nucleophilic substitution of 4 with 3-amino-l-adamantanol. The structure was confirmed by 1H NMR and MS(ESI).
作者 王丽红
出处 《合成化学》 CAS CSCD 2017年第7期620-622,共3页 Chinese Journal of Synthetic Chemistry
基金 国家科技重大项目(2014zx09102043-001)
关键词 L-脯氨酰胺 维格列汀 药物合成 工艺改进 L-prolinamide Vildagliptin drug synthesis process improvement
  • 相关文献

参考文献1

二级参考文献13

  • 1Doupis J, Veves A. DPP4 inhibitors:A new approach in diabetes treatment [ J ]. Adv Ther, 2008,25 : 627 - 643.
  • 2Borja - Hart NL, Whalen KL. Saxagliptin : A new dipeptidyl pep- tidase 4 inhibitor for type 2 diabetes [ J ]. Ann Pharmacother,2010,44:1046 -1053.
  • 3Dalla Man C, Bock G, Giesler PD, et al. Dipeptidyl peptidase - 4 inhibition by vildagliptin and the effect on insulin secretion and action in response to meal ingestion in type 2 diabetes [ J ]. Dia- betes Care, 2009, 32 : 14 - 18.
  • 4Deacon CF, Hoist JJ. Saxagliptin : A new dipeptidyl peptidase - 4 inhibitor for the treatment of type 2 diabetes [ J ]. Adv Ther, 2009,26:488 - 499.
  • 5Hou J, Zheng DZ, Zhou JY, et al. Orexigenic effect of cocaine - and amphetamine - regulated transcript (CART) after injection into hypothalamic nuclei in streptozotocin -diabetic rats [ J ]. Clin Exp Pharmaeol P,2010,37:989 - 995.
  • 6Lee B,Shi L, Kassel DB,et al. Pharmaeokinetic, pharmacodyna- mic, and efficacy profiles of alogliptin, a novel inhibitor of dipep- tidyl peptidase -4,in rats, dogs, and monkeys[ J]. Eur J Phar- macol,2008,589 : 306 - 314.
  • 7Bolen S, Feldman L, Vassy J, et al. Systematic review: compara- tive effectiveness and safety of oral medications for type 2 diabetes mellitus[ J]. Ann Intern Med, 2007, 147:386 - 399.
  • 8Camp I-IS. Thiazolidinediones in diabetes: current status and future outlook [ J ]. Curr Opin Investig Drugs, 2003,4 : 406 - 411.
  • 9DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus [J]. Ann Intem Med,1999, 131:281 -303.
  • 10Stades AM, Heikens JT, Erkelens DW, et al. Metformin and lactic acidosis: cause or coincidence? A review of case reports [ J 1. J Intern Med ,2004,255 : 179 - 187.

共引文献4

同被引文献17

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部